Literature DB >> 33981082

COVID-19 testing turns to T cells.

Cormac Sheridan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33981082     DOI： 10.1038/s41587-021-00920-9

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

Review 1.  Point-of-care diagnostics: recent developments in a pandemic age.

Authors:  Harshit Harpaldas; Siddarth Arumugam; Chelsey Campillo Rodriguez; Bhoomika Ajay Kumar; Vivian Shi; Samuel K Sia
Journal:  Lab Chip       Date:  2021-11-25       Impact factor: 6.799

2.  Molecular and Serologic Diagnostic Technologies for SARS-CoV-2.

Authors:  Halie M Rando; Christian Brueffer; Ronan Lordan; Anna Ada Dattoli; David Manheim; Jesse G Meyer; Ariel I Mundo; Dimitri Perrin; David Mai; Nils Wellhausen; Covid-Review Consortium; Anthony Gitter; Casey S Greene
Journal:  ArXiv       Date:  2022-04-26

3.  T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells.

Authors:  Chang Chu; Anne Schönbrunn; Saban Elitok; Florian Kern; Karsten Schnatbaum; Holger Wenschuh; Kristin Klemm; Volker von Baehr; Bernhard K Krämer; Berthold Hocher
Journal:  Clin Chim Acta       Date:  2022-06-08       Impact factor: 6.314

Review 4.  Utility of Bulk T-Cell Receptor Repertoire Sequencing Analysis in Understanding Immune Responses to COVID-19.

Authors:  Hannah Kockelbergh; Shelley Evans; Tong Deng; Ella Clyne; Anna Kyriakidou; Andreas Economou; Kim Ngan Luu Hoang; Stephen Woodmansey; Andrew Foers; Anna Fowler; Elizabeth J Soilleux
Journal:  Diagnostics (Basel)       Date:  2022-05-13

5.  The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity.

Authors:  Jonathan Pugh; Julian Savulescu; Rebecca C H Brown; Dominic Wilkinson
Journal:  J Med Ethics       Date:  2022-03-07       Impact factor: 5.926
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.